Navigation Links
Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
Date:11/3/2008

BOSTON, Nov. 3 /PRNewswire/ -- Scientists at Schepens Eye Research Institute have found that reducing the levels of vascular endothelial growth factor (VEGF), which is best known as a stimulator of new blood vessel growth, in adult mice causes the death of photoreceptors and Muller glia -- cells of the retina that are essential to visual function. This finding, published in the November 3, 2008 PLoS ONE, holds implications for the chronic use of promising new anti-VEGF drugs such as Lucentis, which eliminate abnormal and damaging blood vessel growth and leakage in the retina by neutralizing VEGF.

"The take home message of this study is that physicians should be vigilant in monitoring patients undergoing anti-VEGF treatments for any possible signs of these side effects," says Principal Investigator Patricia D'Amore, Senior Scientist at Schepens Eye Research Institute. "Drugs such as Lucentis are very good at reducing the edema (fluids) and eliminating the abnormal blood vessels that characterize wet macular degeneration, but our results suggest that there could be unanticipated side effects."

Scientists have long known that VEGF is essential for normal development of the vascular system and for wound healing. It triggers the formation of new blood vessels that nourish the growing body and heal organs and tissues. VEGF also stimulates -- in an apparent misguided attempt to heal perceived damage in the retina -- the growth of abnormal blood vessels that leak and damage delicate retinal tissue.

However, a growing body of evidence also indicates that beyond its impact on blood vessel growth, VEGF may play other vital roles in the adult body and eye, so that eliminating the growth factor might lead to unexpected consequences.

Given the popularity and promise of the new anti-VEGF drugs for the treatment of macular degeneration, D'Amore and her team believed that investigating the broader role of this growth factor in the normal adult reti
'/>"/>

SOURCE Schepens Eye Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Tweens and teens double use of diabetes drugs
2. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
3. Tests Could Predict Benefit From Cancer Drugs
4. Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known
5. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
6. Common Heart Drugs May Hamper Blood Thinner
7. The Market for Disease-Modifying Osteoarthritis Drugs Will Experience Exponential Growth, Increasing From $477 Million in 2007 to Nearly $3.8 Billion in 2017
8. Albertsons LLC Launches $4.99 Prescription Discount Program Covering Over 500 Generic Drugs
9. Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
10. Cholesterol Drugs May Raise Post-Op Delirium Risk
11. First generation antipsychotic drugs as effective as newer ones in some children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Chicago, IL (PRWEB) , ... July 30, 2015 ... ... many patients are living longer and do not find a complete removable denture ... the standard of care. The practices that incorporate less expensive, immediate loading techniques ...
(Date:7/30/2015)... ... ... a lot of focus on the different types of food that need to be eaten as ... successful weight gain is knowing when to eat so that the body has the ... tips on when to eat to gain weight. , The first thing to keep in mind ...
(Date:7/30/2015)... ... July 30, 2015 , ... PeopleKeys, a company with over 30 years ... the Trainer” webinar. The webinar, the newest installment in their popular DISC for the ... Managing Stress: Train the Trainer webinar is intended for people interested in training others ...
(Date:7/29/2015)... ... 30, 2015 , ... Macro Wealth Management (MWM) Presidents have increased ... Lifetime program by encouraging their clients to donate their MWM planning fees to the ... McClellan and Tim Streid, who see charitable giving as an important part of financial ...
(Date:7/29/2015)... ... July 30, 2015 , ... ... clients, BOC approved provider of online continuing education courses for Athletic Trainers ... their exclusive Andrews Research and Education Sports Medicine Series. , The new online ...
Breaking Medicine News(10 mins):Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3
... /Xinhua-PRNewswire/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... and manufacturer of the patented,anti-cancer biotech product Endu ... Carret & Co.,s Fourth Investor Tour of China,being ... April 4, 2008 in Beijing,Shenzhen and Shanghai., ...
... Beef is Eligible to Carry New Consumer Label, ... for the,implementation of E. coli-safeguards, that include new ... cattle, have been,adopted and implemented by VeriPrime, Inc., ... Beef Technical Advisory Council., (Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU070LOGO ...
... Fork, Care and Prevention, WICHITA, Kan., April ... and higher new safety standards, including protections,against E. ... leading farmers and,ranchers behind the food safety seal, ... Citing growing consumer concern over food safety ...
... 1, 2008 Natural,Nutrition, Inc. (OTC Bulletin Board: ... InterACTIVE Nutrition, Inc. (INII) achieved record unaudited,sales of ... EBITDA for the,year ended December 31, 2007., ... are pleased to,report record results for our first ...
... China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ... the research, development, manufacture,and marketing of pharmaceutical, nutritional ... China ("PRC"), announced its financial,results for full year ... 2007 Highlights -- Net sales totaled ...
... American physicians opinions on health-care financing has found that ... national health insurance while only 32 percent oppose it. ... 2002 found 49 percent of physicians supporting national health ... The 2007 survey results demonstrate a significant change in ...
Cached Medicine News:Health News:Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China 2Health News:VeriPrime Approves New Best Practices for Beef Production 2Health News:VeriPrime Approves New Best Practices for Beef Production 3Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 2Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 3Health News:Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 3Health News:China Shenghuo Reports Full Year 2007 Financial Results 4Health News:China Shenghuo Reports Full Year 2007 Financial Results 5Health News:China Shenghuo Reports Full Year 2007 Financial Results 6Health News:China Shenghuo Reports Full Year 2007 Financial Results 7Health News:China Shenghuo Reports Full Year 2007 Financial Results 8Health News:China Shenghuo Reports Full Year 2007 Financial Results 9Health News:China Shenghuo Reports Full Year 2007 Financial Results 10Health News:China Shenghuo Reports Full Year 2007 Financial Results 11Health News:China Shenghuo Reports Full Year 2007 Financial Results 12Health News:China Shenghuo Reports Full Year 2007 Financial Results 13Health News:Indiana University study finds majority of US physicians favor national health insurance 2
(Date:7/29/2015)... PARSIPPANY, N.J. and BERKELEY, Calif. ... Inc. and Plexxikon Inc., a member of the Daiichi ... Journal of Medicine (NEJM) published clinical trial results ... CSF-1R inhibitor, induced prolonged tumor regressions in most patients ... aggressive neoplasm of the joint or tendon sheath. ...
(Date:7/29/2015)... Surgical Company (NASDAQ: STAA ), a leading developer, manufacturer ... eye today reported financial results for the second quarter ended ... , Net Sales of $18.7 Million Down 7% from the ... Million from the Weakening Euro and Yen , ICL ... , APAC Sales Down 1% Including Korea - Up 16% ...
(Date:7/29/2015)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... quarter ended June 30, 2015. "We are ... Fanapt" said Mihael H. Polymeropoulos M.D., Vanda,s President and ... management of our products set the stage for the ... Financial Highlights , Total net product sales for ...
Breaking Medicine Technology:Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9
... Company (NYSE: LLY ) and The Mind ... reform, today announced the launch of The Mind Trust,s ... raise and invest $18 million in the highest-impact education ... students and accelerate education reform. Lilly is investing $2.5 ...
... BETHLEHEM, Pa., May 4, 2011 Germany-based ... U.S. subsidiary B. Braun Medical Inc. (B. Braun) announced ... injunction in its patent infringement case against Japan,s Terumo ... (Logo:   http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) On ...
Cached Medicine Technology:Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 3Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 4B. Braun Obtains Permanent Injunction 2
... Stryker Universal Wedge Screw is ... in cruciate reconstruction and is ... BTB grafts. The Universal Wedge ... and has blunt threads which ...
... combination of a screw and a barbed pin. ... resorbable pins for a hammertoe fixation and prevents ... use! Drill and tap the proximal phalanx. Drill ... the implant proximally. Press fit the barbed portion ...
The Stryker Graft Workstation offers the surgeon flexibility in graft preparation. The posts are interchangeable and the system adapts to both soft tissue and bone grafts selection. Sizing gauges off...
... The Stryker Conquest Suture ... instruments that pierce through ... suture through the tissue ... The Conquest Retrievers are ...
Medicine Products: